Private Capital Advisors, Inc. Amgen Inc Transaction History

Private Capital Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $8.23 Million - $9.8 Million	-38,042 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $17,598 - $19,571	-75 Reduced 0.2%	38,042 $9.67 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 0.13%	38,117 $8.99 Million
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $23,144 - $30,695	-127 Reduced 0.33%	38,167 $7.74 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $14,190 - $18,240	-75 Reduced 0.2%	38,294 $9.23 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $26,116 - $31,293	-150 Reduced 0.39%	38,369 $7.43 Million
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $33,340 - $39,082	200 Added 0.52%	38,519 $7.1 Million
Q1 2019 Apr 09, 2019	BUY	$180.87 - $203.88 $23,874 - $26,912	132 Added 0.35%	38,319 $7.28 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $7.08 Million - $7.98 Million	38,187 New	38,187 $7.92 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $6.91 Million - $7.79 Million	-37,309 Closed	0 $0
Q2 2018 Jul 10, 2018	BUY	$166.05 - $186.51 $155,090 - $174,200	934 Added 2.57%	37,309 $6.89 Million
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $6.16 Million - $7.2 Million	36,375 New	36,375 $6.2 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Private Capital Advisors, Inc. with notifications on news.